Symptom dimensions in obsessive-compulsive disorder: Phenomenology and treatment outcomes with exposure and ritual prevention

Psychopathology

Volumn 46, Issue 6, 2013, Pages 365-376

  Williams, Monnica T ^a   Mugno, Beth ^b   Franklin, Martin ^b   Faber, Sonya ^c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Bioville GmbH   (Germany)

Author keywords

Cognitive behavioral therapy; Exposure and ritual prevention; Obsessive compulsive disorder; Symptoms; Treatment; Treatment outcome

Indexed keywords

COGNITIVE THERAPY; COMPULSION; HUMAN; MALE; MIDDLE AGED; OBSESSIVE COMPULSIVE DISORDER; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; REVIEW; SYMBOLISM;

CEREMONIAL BEHAVIOR; COGNITIVE THERAPY; COMPULSIVE BEHAVIOR; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PRIMARY PREVENTION;

EID: 84887030283     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000348582     Document Type: Review

References (97)

1. Sussman N: Obsessive-compulsive disorder: a commonly missed diagnosis in primary care. Prim Psychiatry 2003; 10: 14. (Pubitemid 38435944)
2. Ruscio A, Stein D, Chiu W, Kessler R: The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15: 53-63.
3. Goodman W, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Charney D: The Yale-Brown Obsessive Compulsive Scale Part I. Development, use and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
4. Baer L: Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994; 55: 18-23. (Pubitemid 24113071)
5. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, et al: Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 911-917. (Pubitemid 27274532)
6. Mataix-Cols D, Rauch S, Manzo P, Jenike M, Baer L: Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156: 1216-1409.
7. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM: Symptom presentation and outcome of cognitive-behavioral therapy for obsessivecompulsive disorder. J Consult Clin Psychol 2003; 71: 1049-1057. (Pubitemid 37448895)
8. Denys D, de Geus F, van Megen H, Westenberg H: Symptom dimensions in obsessivecompulsive disorder: factor analysis on a clinician- rated scale and self-report measure. Psychopathology 2004; 37: 181-189. (Pubitemid 39194370)
9. Pinto A, Eisen J, Mancebo M, Greenberg B, Stout R, Rasmussen S: Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Res 2007; 151: 255-258. (Pubitemid 46829414)
10. Pinto A, Greenberg B, Grados M, Bienvenu III O, Samuels J, Murphy D, Shugart Y: Further development of Y-BOCS dimensions in the OCD collaborative genetics study: symptoms versus categories. Psychiatry Res 2008; 160: 83-93.
11. Williams MT, Farris SG, Turkheimer E, Pinto A, Ozanick K, Franklin ME, Liebowitz M, Simpson HB, Foa EB: The myth of the pure obsessional type in obsessive-compulsive disorder. Depress Anxiety 2011; 28: 495-500.
12. Bloch M, Landeros-Weisenberger A, Rosario M, Pittenger C, Leckman J: Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 1532-1542.
13. Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, Timpano KR, McGrath PB, Riemann BC, Adams T, et al: Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychol Assess 2010; 22: 180- 198.
14. Garcia-Soriano G: Pensamientos intrusos obsesiones clinicas: contenidos y significado personal. Servei de Publicaciones 2008.
15. Garcia-Soriano G, Belloch A, Morillo C, Clark D: Symptom dimensions in obsessive-compulsive disorder: from normal cognitive intrusions to clinical obsessions. J Anxiety Disord 2011; 25: 474-482.
16. Viar M, Bilsky S, Armstrong T, Olatunji B: Obsessive beliefs and dimensions of obsessive- compulsive disorder: an examination of specific associations. Cogn Ther Res 2011; 35: 108-117.
17. Wheaton M, Abramowitz J, Berman N, Riemann B, Hale L: The relationship between obsessive beliefs and symptom dimensions in obsessive-compulsive disorder. Behav Res Ther 2010; 48: 949-954.
18. Lee H, Kwon S: Two different types of obsessions: autogenous obsessions and reactive obsessions. Behav Res Ther 2003; 41: 11-29. (Pubitemid 35463181)
19. Besiroglu L, Uguz F, Ozbebit O, Guler O, Cilli A, Askin R: Longitudinal assessment of symptom and subtype categories in obsessive- compulsive disorder. Depress Anxiety 2007; 24: 461-466. (Pubitemid 350086258)
20. Moulding R, Kyrios M, Doron G, Nedeljkovic M: Autogenous and reactive obsessions: further evidence for a two factor model of obsessions. J Anxiety Disord 2007; 21: 677-690. (Pubitemid 46830745)
21. Taberner J, Fullana M, Caseras X, Pertusa A, Bados A, van den Bree M, Mataix-Cols D: Are obsessive-compulsive symptom dimensions familial in non-clinical individuals? Depress Anxiety 2009; 26: 902-908.
22. Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, Knowles JA, McCracken JT, Piacentini J, Riddle MA, et al: Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry 2007; 61: 617-625. (Pubitemid 46328863)
23. Katerberg H, Delucchi KL, Stewart SE, Lochner C, Denys DA, Stack DE, Andresen JM, Grant JE, Kim SW, Williams KA, et al: Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 2010; 40: 505-517.
24. Jenike M, Baer L, Minichiello W, Rauch S, Buttolph M: Placebo-controlled trial of fluoxetine and phenelzine for obsessive-control disorder. Am J Psychiatry 1997; 154: 1261- 1264. (Pubitemid 27369178)
25. Stein D, Anderson E, Overo K: Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Rev Bras Psiquiatr 2007; 29: 303-307. (Pubitemid 351358053)
26. Saxena S, Brody A, Maidment K, Baxter L: Paroxetine treatment of compulsive hoarding. J Psychiatr Res 2007; 41: 481-487. (Pubitemid 46227443)
27. Alonso P, Menchon JM, Pifarre J, Mataix- Cols D, Torres L, Salgado P, Vallejo J: Long term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001; 62: 535-540. (Pubitemid 32703093)
28. Rauch S, Dougherty D, Shin L, Alpert N, Manzo P, Leahy L: Neural correlates of factoranalyzed OCD symptom dimensions: a PET study. CNS Spectr 1998; 3: 37-43. (Pubitemid 29128220)
29. Mataix-Cols D, Woodersons S, Lawrence N, Brammer M, Speckens A, Phillips M: Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessivecompulsive disorder. Arch Gen Psychiatry 2004; 61: 564-576. (Pubitemid 38747311)
30. Van den Heuvel O, Remijnse P, Mataix-Cols D, Vrenken H, Groenewegen H, Uylings H, Veltman D: The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009; 132: 853-868.
31. Alonso P, Gratacos M, Segalas C, Escaramis G, Real E, Bayes M, Labad J, Pertusa A, Vallejo J, Estivill X, et al: Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder. Psychoneuroendocrinology 2011; 36: 473-483.
32. Taylor S, Jang KL: Biopsychosocial etiology of obsessions and compulsions: an integrated behavioral-genetic and cognitive-behavioral analysis. J Abnorm Psychol 2011; 120: 174- 186.
33. Taylor S, Jang KL, Asmundson GG: Etiology of obsessions and compulsions: a behavioralgenetic analysis. J Abnorm Psychol 2010; 119: 672-682.
34. Taylor S: Molecular genetics of obsessivecompulsive disorder: a comprehensive metaanalysis of genetic association studies. Mol Psychiatry, E-pub ahead of print.
35. Meyer V: Modification of expectations in cases with obsessional rituals. Behav Res Ther 1966; 4: 273-280.
36. March J, Frances A, Kahn D, Carpenter D: The expert consensus guideline series: treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997; 58: 1-72.
37. NCCMH: Obsessive-compulsive disorder: core interventions in the treatment of obsessive- compulsive disorder and body dysmorphic disorder. London, British Psychological Society and Royal College of Psychiatrists, 2006.
38. Franklin M, Abramowitz J, Levitt J, Foa E: Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with non-randomized samples. J Consult Clin Psychol 2000; 68: 594-602.
39. Foa E, Yadin E, Lichner T: Exposure and response (ritual) prevention for obsessive-compulsive disorder, ed 2. New York, Oxford University Press, 2012.
40. Williams M, Powers M, Foa E: Psychological treatment for obsessive-compulsive disorder; in: Handbook of Evidence-Based Practice in Clinical Psychology. Vol II. Adult Disorders. New York, Wiley, 2012.
41. Sookman D, Abramowitz JS, Calamari JE, Wilhelm S, McKay D: Subtypes of obsessivecompulsive disorder: implications for specialized cognitive behavior therapy. Behav Ther 2005; 36: 393-400.
42. Salkovskis P: Cognitive-behavioral factors and the persistence of intrusive thoughts in obsessional problems. Behav Res Ther 1989; 27: 677-682. (Pubitemid 20060834)
43. Leckman JF, Denys D, Simpson HB, Mataix- Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, et al: Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 2010; 27: 507-527.
44. Mataix-Cols D, Frost RO, Pertusa A, Clark LA, Saxena S, Leckman JF, Stein DJ, Matsunaga H, Wilhelm S: Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety 2010; 27: 556-572.
45. Ball SG, Baer L, Otto M: Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther 1996; 34: 47-51. (Pubitemid 126755202)
46. Radomsky A, Rachman S: Symmetry, ordering and arranging compulsive behavior. Behav Res Ther 2004; 42: 893-913. (Pubitemid 38721242)
47. Feinstein S, Fallon B, Petkova E, Leibowitz M: Item-by-item factor analysis of the Yale- Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci 2003; 15: 187-193. (Pubitemid 36520338)
48. Foa E, Goldstein A: Continuous exposure and complete response prevention of obsessivecompulsive disorder. Behav Ther 1978; 9: 821- 829. (Pubitemid 9144111)
49. Foa E, Kozak M, Steketee G, McCarthy P: Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. J Clin Psychol 1992; 31: 279-292.
50. De Araujo L, Ito L, Marks I, Deale A: Does imagined exposure to the consequences of not ritualising enhance live exposure for OCD? A controlled study. Br J Psychiatry 1995; 167: 18165-70189.
51. McLean PD, Whittal ML, Thordarson DS, Taylor S, Sochting I, Koch WJ, Paterson R, Anderson KW: Cognitive versus behavior therapy in the group treatment of obsessivecompulsive disorder. J Consult Clin Psychol 2001; 69: 205-214. (Pubitemid 32488279)
52. Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM: Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as control. J Clin Psychiatry 2002; 63: 138-145. (Pubitemid 34173851)
53. Foa E, Steketee G, Grayson J, Turner R, Latimer P: Deliberate exposure and blocking of obsessive-compulsive rituals: immediate and long-term effects. Behav Ther 1984; 15: 450- 472. (Pubitemid 15175426)
54. Jones M, Menzies R: Danger ideation reduction therapy (DIRT) for obsessive-compulsive washers. A controlled trial. Behav Res Ther 1998; 36: 959-970. (Pubitemid 28391280)
55. Krochmalik A, Jones M, Menzies R, Kirkby K: The superiority of danger ideation reduction therapy (DIRT) over exposure and response prevention (ERP) in treating compulsive washing. Behav Change 2004; 21: 251-268. (Pubitemid 40585153)
56. Smits J, Talch M, Randall P: An examination of the decline in fear and disgust during exposure- based treatment. Behav Res Ther 2002; 40: 1243-1253.
57. Olatunji B, Wolitzky-Taylor K, Willems J, Lohr J, Armstrong T: Differrential habituation of fear and disgust during exposure to threat-relevant stimuli in contaminationbased OCD: an analogue study. J Anxiety Disord 2009; 23: 118-123.
58. McKay D: Treating disgust reactions in contamination- based obsessive-compulsive disorder. J Behav Ther Exp Psychiatry 2006; 37: 53-59. (Pubitemid 41735355)
59. McKay D, Abramowitz J, Calamari J, Kyrios M, Radomsky A, Sookman D, Wilhelm S: A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms. Clin Psychol Rev 2004; 24: 283-313. (Pubitemid 38881544)
60. Shafran R, Thordarson DS, Rachman S: Thought-action fusion in obsessive-compulsive disorder. J Anxiety Disord 1996; 10: 379- 391.
61. Woods C, Vevea J, Chambless D, Bayen U: Are compulsive checkers impaired in memory? A meta-analytic review. Clin Psychol 2002; 9: 353-366.
62. Rachman S: A cognitive theory of compulsive checking. Behav Res Ther 2002; 40: 625-639. (Pubitemid 34462997)
63. Boschen MJ, Vuksavonic D: Deteriorating memory confidence, responsibility perceptions and repeated checking: comparisons in OCD and control samples. Behav Res Ther 2007; 45: 2098-2109. (Pubitemid 47210959)
64. Whiteside S, Abramowitz J: The expression of anger and its relationship to symptoms and cognitions in obsessive-compulsive disorder. Depress Anxiety 2005; 21: 106-111. (Pubitemid 41040632)
65. Radomsky A, Ashbaugha A, Gelfand L: Relationships between anger, symptoms, and cognitive factors in OCD checkers. Behav Res Ther 2007; 45: 2712-2725. (Pubitemid 47513651)
66. Foa E, Huppert E, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis P: The obsessivecompulsive inventory: development and validation of a short version. Psychol Assess 2002; 14: 485-496. (Pubitemid 35440493)
67. Cromer K, Schmidt N, Murphy D: An investigation of traumatic life events and obsessive- compulsive disorder. Behav Res Ther 2007; 45: 1683-1691. (Pubitemid 46669436)
68. Basoglu M, Lax T, Kavikis Y, Marks I: Predictors of improvement in obsessive-compulsive disorder. J Anxiety Disord 1988; 2: 299-317.
69. Drummond L: The treatment of severe, chronic, resistant obsessive-compulsive disorder: an evaluation of an in-patient program using behavioral psychotherapy in combination with other treatments. Br J Psychiatry 1993; 163: 223-229. (Pubitemid 23233092)
70. Foa E, Kozak M, Goodman W, Hollander E, Jenike M, Rasmussen S: DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry 1995; 152: 90-96.
71. Ghisi M, Chiri L, Marchetti I, Sanavio E, Sica C: In search of specificity: 'not just right experiences' and obsessive-compulsive symptoms in non-clinical and clinical Italian individuals. J Anxiety Disord 2010; 24: 879-886.
72. OCCW Group: Psychometric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory. Part 1. Behav Res Ther 2003; 41: 1245-1264.
73. Rachman S: A cognitive theory of obsessions: elaborations. Behav Res Ther 1998; 36: 385- 401. (Pubitemid 28256914)
74. Williams M, Farris S: Sexual orientation obsessions in obsessive-compulsive disorder: prevalence and correlates. Psychiatry Res 2011; 187: 156-159.
75. Grant J, Pinto A, Gunnip B, Mancebo M, Eisen J, Rasmussen S: Sexual obsessions and clinical correlates in adults with obsessivecompulsive disorder. Compr Psychiatry 2006; 47: 325-329 (Pubitemid 44192530)
76. Rufer M, Fricke S, Moritz S, Kloss M, Hand I: Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand 2006; 113: 440-446.
77. Mataiz-Cols D, Marks I, Greist J, Kobak KA, Baer L: Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002; 71: 255-262. (Pubitemid 35007649)
78. Gillihan S, Williams MT, Malcoun E, Yadin E, Foa EB: Common pitfalls in exposure and ritual prevention (EX/RP) for obsessive-compulsive disorder. J Obsessive Compuls Relat Disord 2012; 14: 251-257.
79. Freeston M, Ladouceur R, Gagnon F, Thibodeau N, Rheaume J, Letarte H, Bujold A: Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol 1997; 653: 405-413. (Pubitemid 27246781)
80. Freeston K, Leger E, Ladouceur R: Cognitive therapy of obsessive thoughts. Cogn Behav Pract 2001; 8: 61-78. (Pubitemid 33127080)
81. Abramowitz J, Zoellner L: Cognitive-behavior therapy as an adjunct to medication for obsessive-compulsive disorder with mental rituals: a pilot study. J Cogn Behav Psychother 2002; 2: 11-22.
82. Whittal M, McLean P, Woody S, Rachman S, Robichaud M: Treatment of obsessions: a randomized controlled trial. Behav Res Ther 2010; 48: 295-303.
83. Summerfeldt L: Understanding and treating incompleteness in obsessive-compulsive disorder. J Clin Psychol 2004; 60: 1155-1168. (Pubitemid 39392088)
84. Calamari J, Cohen R, Rector N, Szacun-Shimizu K, Riemann B, Norberg M: Dysfunctional belief-based obsessive-compulsive disorder subgroups. Behav Res Ther 2006; 44: 1347-1360. (Pubitemid 44093431)
85. Taylor S, Abramowitz J, McKay D, Calamari J, Sookman D, Kyrios M, Wilhelm S, Carmin C: Do dysfunctional beliefs play a role in all types of obsessive-compulsive disorder? J Anxiety Disord 2006; 20: 85-97. (Pubitemid 41735189)
86. Grabe H, Goldschmidt F, Lehmkuhl L, Gänsicke M, Spitzer C, Freyberger H: Dissociative symptoms in patients with obsessive-compulsive disorder. Psychopathology 1999; 32: 319- 324.
87. Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, Greenberg BD, Murphy DL: Obsessive-compulsive disorder symptom dimensions. Biol Psychiatry 2005; 135: 121-132.
88. Albert U, Maina G, Forner F, Bogetto F: DSM-IV obsessive-compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects. Compr Psychiatry 2004; 45: 325-332. (Pubitemid 39140884)
89. Garyfallos G, Katsigiannopoulos K, Adamopoulou A, Papazisis G, Karastergiou A, Bozikas V: Comorbidity of obsessive-compulsive disorder with obsessive-compulsive personality disorder: does it imply a specific subtype of obsessive-compulsive disorder? Psychiatry Res 2010; 177: 156-160.
90. Pinto A, Mancebo M, Eisen J, Pagano M, Rasmussen S: The Brown Longitudinal Obsessive- Compulsive Study: clinical features and symptoms of the sample of intake. J Clin Psychiatry 2006; 67: 703-711. (Pubitemid 43946176)
91. Samuels J, Eaton W, Bienvenu IO, Brown C, Costa JP, Nestadt G: Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry 2002; 180: 536-542. (Pubitemid 34596805)
92. Eisen JL, Coles ME, Shea MT, Pagano ME, Stout RL, Yen S, Grilo CM, Rasmussen SA: Clarifying the convergence between obsessive- compulsive personality disorder criteria and obsessive-compulsive disorder. J Pers Disord 2006; 20: 294-305.
93. Alonso P, Segalas C, Real E, Pertusa A, Labad J, Jimenez-Murcia S, Jaurrieta N, Bueno B, Vallejo J, Menchon JM: Suicide in patients treated for obsessive-compulsive disorder: a prospective follow-up study. J Affect Disord 2010; 124: 300-308.
94. Daniel S, Goldston D, Erklani A, Franklin J, Mayfield A: Trait anger, anger expression, and suicide attempts among adolescents and young adults: a prospective study. J Clin Child Adolesc Psychol 2009; 38: 661-671.
95. Rufer M, Grothusen A, Mass R, Peter H, Hand I: Temporal stability of symptom dimensions in adult patients with obsessivecompulsive disorder in the National Survey Comorbidity Survey Replication. J Affect Disord 2005; 88: 99-102. (Pubitemid 41160420)
96. Mataix-Cols D, Rosario-Campos M, Leckman J: A multidimensional model of obsessive- compulsive disorder. Am J Psychiatry 2005; 162: 228-238. (Pubitemid 40216199)
97. Leckman J, Grice D, Barr L, de Vries A, Martin C, Cohen D, McDougle C, Goodman W, Rasmussen S: Tic-related versus non-tic-related obsessive compulsive disorder. Anxiety 1995; 1: 208-221.